A US Food and Drug Administration perspective on evaluating medical products for Ebola

Abstract

Keywords

Therapeutic clinical trials vaccine clinical trials Ebola

Get full access to this article

View all access options for this article.

References

Krause

Cavaleri

Coleman

. Approaches to demonstration of Ebola virus vaccine efficacy. Lancet Infect Dis 2015 6: 627–629.

Bellam

Pulliam

Pearson

. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015; 15: 703–710.

Ebola ca Suffit Ring Vaccination Consortium. The ring vaccination trial: a novel cluster randomized controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ 2015; 351: h3740.

Henao-Restrepo

Longini

Egger

. Efficacy and effectiveness of using an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386: 857–866.

Krause

PR.

Interim results from a phase 3 Ebola vaccine study in Guinea. Lancet 2015; 386: 831–833.

US Department of Health and Human Services. Food and drug administration. Product development under the animal rule. Guidance for Industry, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm399217.pdf (2015, accessed 5 November 2015).

Krause

Bryant

Clark

. Immunology of protection from Ebola virus infection. Sci Transl Med 2015; 7: 286ps11.

Food and Drug Administration. Transcript of advisory committee. May 2015, http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM453283.pdf (2015, accessed 5 November 2015).

Cox

Borio

Temple

Evaluating Ebola therapies—the case for RCTs. New Engl J Med 2014; 371: 2350–2351.

10.

The International Council for Harmonisation. Choice of control group and related issues in clinical trials, E10, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf (2000, accessed 5 November 2015).

11.

Adebamowo

Bah-Sow

Binka

. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014; 384: 1423–1424.

12.

Cooper

Boni

Pan-ngum

. Evaluating clinical trial designs for investigational treatments of Ebola virus disease. PLoS Med 2015; 12: e1001815.

13.

Schieffelin

Shaffer

Goba

. Clinical illness and outcomes in patients with Ebola in Sierra Leone. New Engl J Med 2014; 371: 2092–2100.

14.

Ansumana

Jacobsen

Sahr

. Ebola in Freetown area, Sierra Leone—a case study of 581 patients. New Engl J Med 2015; 372: 587–588.